AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Changzhou Yinsheng Pharmaceutical Co., Ltd., established on 2003-04-21, Business scope includes pharmaceuticals(Operating according to the items listed in the drug production license)manufacturing;Production and sale of non-pharmaceutical chemical barium sulfate;Self-operated and agent import and export business of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Technology development in the field of medicine,Technical Services,technical consulting,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Medivir AB engages in the development of pharmaceuticals products. The firm focuses on the discovery and development of transformative active cancer drugs. Its portfolio includes proprietary pipelines such as remetinostat, birinapant, MV-818, MV-828, and MIV-711 projects; and partnership pipeline which covers xerclear and MIV-802 project. The company was founded in 1988 and is headquartered in Huddinge, Sweden.

Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonâ). This complementary group of platform technologies has the potential to generate a number of distinct therapeutic products to treat a variety of serious viral infections such as chronic hepatitis B and C, HIV infection, and respiratory viruses (e.g. pandemic influenza) and emerging viral diseases (e.g. SARS).

China State Institute of Pharmaceutical Industry is a company headquartered in Shanghai, China and ultimately controlled by the Government of China. The firm regulates pharmaceutical companies.

Optimus Drugs Pvt Ltd. engages in the manufacture of pharmaceutical products. It offers antihyperparathyroid, antidepressant, antifungal, antithrombotic, anticonvulsant, antibacterial, antipsychotic, antiretroviral, protease inhibitor, and aldosterone antagonist. The company was founded by Srinivasa Reddy in 2004 and is headquartered in Hyderabad, India.

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

Jiangsu Yangtze River Pharmaceutical Group Co., Ltd. manufactures and distributes pharmaceutical products. It is a large cross-regional pharmaceutical group that features industry-university-institute cooperation and integrates scientific research, industrial production and sale. The company was founded in 1971 and is headquartered in Taizhou, China.

Mylan Laboratories Ltd. manufactures and supplies active pharmaceutical ingredients. The firm operates through two segments: Pharmaceuticals and Medical Supplies. It manufactures and supplies generic and branded generic formulations to various markets, including North America, Europe and Asia Pacific. Mylan Laboratories was founded on November 29, 1984 and is headquartered in Hyderabad, India.

Shanghai Zhongqiang Pharmaceutical Co., Ltd., established on 2014-06-12, Business scope includes pharmaceuticals,biopharmaceuticals(remove human stem cells,Development and application of genetic diagnosis and treatment technology),Pharmaceutical Intermediates(In addition to biological reagents),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)research and development;medicine,Pharmaceutical Intermediates(In addition to biological reagents),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),laboratory consumables,Instrumentation,Wholesale of electronic products,import and export,and provide supporting services.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Nanchangyou Pharmaceutical Technology Co., Ltd., established on 2011-05-19, Business scope includes research and development of pharmaceutical technology;Chemical Products(Rosuvastatin Calcium,Aliskiren,Pregabalin,ezetimibe,Sofosbuvir,Ticagrelor,Canagliflozin,Daclatasvir dihydrochloride,Shakubi,Velpatasvir copovidone,Rivaroxaban,Raw material of celecoxib)Production,Sales;Self-management and agency of various commodity import and export business(Except for goods that the state restricts the company to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zentiva ks specializes in the development, manufacture and marketing of generic pharmaceutical products. It offers generic drugs, over the counter medicines, dietary supplements, cosmetics and pharmaceutical substances. The company's products cover therapy areas of cardiovascular disease, pain, alimentary, genitourinary tract diseases, inflammations and central nervous system diseases including digestive problems. Zentiva was founded in 1989 and is headquartered in Prague, Czech Republic.

Shanghai Buyue Chemical Technology Co., Ltd., established on 2012-03-14, The scope of business includes engaging in chemical technology,Technology development in the field of biotechnology,technology transfer,technical consulting,Technical Services,Engaged in the import and export of goods and technology,Instrumentation,Laboratory equipment installation,repair,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Instrumentation,Daily necessities,electronic product,metallic material,Rubber products,electrical tools,Electrical Equipment,auto parts,Wholesale of motorcycle accessories,retail. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Laurus labs is an innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry. Equipped with a world-class infrastructure manned by best-in-class personnel & driven by the core values of knowledge, innovation and excellence, within a relatively short period, Laurus labs emerged as a segment-leading manufacturer of high quality APIs, a preferred partner for NCE development & manufacture & a trusted source of specialty ingredients for the nutraceutical industry. Given the strengths, capabilities & experience, Laurus Labs is uniquely positioned to help its clients in their endeavor of ‘quicker to market’ & thus contributing towards improving access to quality & affordable healthcare worldwide.

Anhui Yiling Pharmaceutical Co., Ltd., established on 2014-07-28, Business scope includes biotechnology development,transfer;Import and export business;Pharmaceutical Intermediates,Chemical Products(Free of chemical hazards,Flammable and Explosives;Except for those expressly prohibited by the state)Sales,Production,Processing(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

AZAD Pharmaceutical Ingredients AG is a private company headquartered in Schaffhausen, Switzerland. The firm manufactures pharmaceuticals products.